Study to Evaluate Pharmacokinetics, Pharmacodynamics, and Safety of Sargramostim Administered Subcutaneously, Intravenously, or by Inhalation
Clinical trial NCT05366283 · COMPLETED
Trial details
- NCT number
- NCT05366283
- Sponsor
- Partner Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-13
- Primary completion
- 2022-05-27
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.